Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 6 (2019)

Quantification of valsartan and hydrochlorothiazide in bulk and tablet formulation by RP-HPLC method

Author(s):
Jyothsna Modugula, Sushma Rachamalla, Manohar Reddy Jakkireddy, Indira Devi P, Venkata Seshagiri Podili and Krishnaveni Kamepalli
Abstract:
A simple, economic, selective and precise RP-HPLC method has been developed and validated for Valsartan and Hydrochlorothiazidein bulk and tablet dosage form. The isocratic LC analysis was performed on Inertsil BDS C18 column (250 mm x 4.6 mm, 5 µ) using mobile phase composed of Methanol and 0.05M phosphate buffer pH 4.5 (55:45 v/v) at a flow rate of 1.0 ml/min. Quantitation was performed using UV detector at 281 nm. The retention time was found to be 3.541min for Valsartan and 5.221min for Hydrochlorothiazide. The analytical method was validated according to ICH guidelines. The linearity was observed in the range of 20-60 µg/ml for both Valsartan and 99.67 to 99.94 % for Hydrochlorothiazide with correlation coefficients (r2) are 0.999 for Valsartan and 0.998 for Hydrochlorothiazide. The % recovery was found to be 100.12 - 100.89 % for Valsartan and Hydrochlorothiazide. The relative standard deviation values for repeatability and intermediate precision studies were less than 2%. The proposed method was precise, rapid, accurate, and cost-effective and can be used for the routine estimation for Valsartan and Hydrochlorothiazidein tablet dosage form.
Pages: 999-1008  |  319 Views  57 Downloads


The Pharma Innovation Journal
How to cite this article:
Jyothsna Modugula, Sushma Rachamalla, Manohar Reddy Jakkireddy, Indira Devi P, Venkata Seshagiri Podili, Krishnaveni Kamepalli. Quantification of valsartan and hydrochlorothiazide in bulk and tablet formulation by RP-HPLC method. Pharma Innovation 2019;8(6):999-1008.

Call for book chapter